313 results on '"Mabilleau, Guillaume"'
Search Results
2. Narrative Review of Effects of Glucagon-Like Peptide-1 Receptor Agonists on Bone Health in People Living with Obesity
3. Gut hormone analogues and skeletal health in diabetes and obesity: Evidence from preclinical models
4. Validation of Fourier Transform Infrared Microspectroscopy for the Evaluation of Enzymatic Cross-Linking of Bone Collagen
5. Effects of vertical sleeve gastrectomy prior to pregnancy on bone mass, microarchitecture and material properties in the female rat
6. Superpixels meet essential spectra for fast Raman hyperspectral microimaging
7. Narrative Review of Effects of Glucagon-Like Peptide-1 Receptor Agonists on Bone Health in People Living with Obesity
8. Differences in bone microarchitecture between genetic and secondary iron‐overload mouse models suggest a role for hepcidin deficiency in iron‐related osteoporosis
9. Acetoacetate protects macrophages from lactic acidosis-induced mitochondrial dysfunction by metabolic reprograming
10. Dapagliflozin and Liraglutide Therapies Rapidly Enhanced Bone Material Properties and Matrix Biomechanics at Bone Formation Site in a Type 2 Diabetic Mouse Model
11. Sclerostin-Antibody Treatment Decreases Fracture Rates in Axial Skeleton and Improves the Skeletal Phenotype in Growing oim/oim Mice
12. Sclerostin antibody reduces long bone fractures in the oim/oim model of osteogenesis imperfecta
13. An overview of cellular ultrastructure in benthic foraminifera: New observations of rotalid species in the context of existing literature
14. Sitagliptin Alters Bone Composition in High-Fat-Fed Mice
15. Bone mineralization and vascularization in bisphosphonate-related osteonecrosis of the jaw: an experimental study in the rat
16. Beneficial Effects of Zoledronic Acid on Tendons of the Osteogenesis Imperfecta Mouse (Oim)
17. Predicting Bone Regeneration with a Simple Blood Test
18. Improved methodology for measuring pore patterns in the benthic foraminiferal genus Ammonia
19. Glucose-dependent insulinotropic polypeptide (GIP) dose-dependently reduces osteoclast differentiation and resorption
20. Lrp5p. Val667Met Variant Compromises Bone Mineral Density and Matrix Properties in Osteoporosis
21. Validation of Fourier transform infrared microspectroscopy for the evaluation of enzymatic cross-linking of bone collagen
22. High fat-fed diabetic mice present with profound alterations of the osteocyte network
23. A new stable GIP–Oxyntomodulin hybrid peptide improved bone strength both at the organ and tissue levels in genetically-inherited type 2 diabetes mellitus
24. Aluminum and iron can be deposited in the calcified matrix of bone exostoses
25. Alteration of the bone tissue material properties in type 1 diabetes mellitus: A Fourier transform infrared microspectroscopy study
26. Incretins and bone: friend or foe?
27. Glucose-dependent insulinotropic polypeptide (GIP) directly affects collagen fibril diameter and collagen cross-linking in osteoblast cultures
28. Three-dimensional arrangement of β-tricalcium phosphate granules evaluated by microcomputed tomography and fractal analysis
29. Prevalence of Osteoporosis in Myelodysplastic Syndrome Patients and Association with Cytopenias
30. Hypodynamia Alters Bone Quality and Trabecular Microarchitecture
31. Complexe ostéotendineux et ostéogenèse imparfaite – Caractérisation chez la souris oim
32. Biomechanical, Microstructural and Material Properties of Tendon and Bone in the Young Oim Mice Model of Osteogenesis Imperfecta
33. Development of a first-in-class unimolecular dual GIP/GLP-2 analogue, GL-0001, for the treatment of bone fragility
34. Beneficial effects of a N-terminally modified GIP agonist on tissue-level bone material properties
35. Incretin-based therapy for the treatment of bone fragility in diabetes mellitus
36. Lrp5 p.Val667Met Variant Compromises Bone Mineral Density and Matrix Properties in Osteoporosis.
37. Development of a First‐in‐Class Unimolecular Dual GIP/GLP‐2 Analogue, GL‐0001, for the Treatment of Bone Fragility.
38. Aluminum inhibits the growth of hydroxyapatite crystals developed on a biomimetic methacrylic polymer
39. Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and quality
40. The rare p.Val667Met (V667M) variant of LRP5 is responsible for bone fragility through alteration of the bone matrix quality in mice
41. Glucose-dependent insulinotropic polypeptide receptor deficiency leads to modifications of trabecular bone volume and quality in mice
42. Depth and volume of resorption induced by osteoclasts generated in the presence of RANKL, TNF-alpha/IL-1 or LIGHT
43. Review for "Combinatorial Inhibition of Myostatin and Activin A improves Femoral Bone Properties in theG610Cmouse model of Osteogenesis Imperfecta"
44. Osteomorphs as a tool for personalized medicine
45. [Gly²]-GLP-2, But Not Glucagon or [D-Ala²]-GLP-1, Controls Collagen Crosslinking in Murine Osteoblast Cultures
46. Caveolin-1 Expression and Cavin Stability Regulate Caveolae Dynamics in Adipocyte Lipid Store Fluctuation
47. Chemical structure of methylmethacrylate-2-[2′,3′,5′-triiodobenzoyl]oxoethyl methacrylate copolymer, radio-opacity, in vitro and in vivo biocompatibility
48. Effects of FGF-2 release from a hydrogel polymer on bone mass and microarchitecture
49. Iron inhibits hydroxyapatite crystal growth in vitro
50. Use of glucagon-like peptide-1 receptor agonists and bone fractures: A meta-analysis of randomized clinical trials
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.